![Progression-Free Survival and Time to Progression as Real Surrogate End Points for Overall Survival in Advanced Breast Cancer: A Meta-Analysis of 37 Trials - ScienceDirect Progression-Free Survival and Time to Progression as Real Surrogate End Points for Overall Survival in Advanced Breast Cancer: A Meta-Analysis of 37 Trials - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1526820916303585-gr1.jpg)
Progression-Free Survival and Time to Progression as Real Surrogate End Points for Overall Survival in Advanced Breast Cancer: A Meta-Analysis of 37 Trials - ScienceDirect
![Progression-free survival as a surrogate endpoint in advanced neuroendocrine neoplasms in: Endocrine-Related Cancer Volume 24 Issue 9 (2017) Progression-free survival as a surrogate endpoint in advanced neuroendocrine neoplasms in: Endocrine-Related Cancer Volume 24 Issue 9 (2017)](https://erc.bioscientifica.com/view/journals/erc/24/9/images/large/full-475fig2.jpeg)
Progression-free survival as a surrogate endpoint in advanced neuroendocrine neoplasms in: Endocrine-Related Cancer Volume 24 Issue 9 (2017)
![Progression-free survival and time to progression as primary end points in advanced breast cancer: often used, sometimes loosely defined - Annals of Oncology Progression-free survival and time to progression as primary end points in advanced breast cancer: often used, sometimes loosely defined - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/ab41f9ea-1e95-4e97-8aeb-893307dbc238/gr1.jpg)
Progression-free survival and time to progression as primary end points in advanced breast cancer: often used, sometimes loosely defined - Annals of Oncology
![Progression-free survival at 2 years is a reliable surrogate marker for the 5-year survival rate in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy | BMC Cancer | Full Progression-free survival at 2 years is a reliable surrogate marker for the 5-year survival rate in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy | BMC Cancer | Full](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-2407-14-18/MediaObjects/12885_2013_Article_4261_Fig1_HTML.jpg)
Progression-free survival at 2 years is a reliable surrogate marker for the 5-year survival rate in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy | BMC Cancer | Full
![A, Progression-free survival (PFS) and B, overall survival (OS) after... | Download Scientific Diagram A, Progression-free survival (PFS) and B, overall survival (OS) after... | Download Scientific Diagram](https://www.researchgate.net/profile/Gregory-Jones-11/publication/338814164/figure/fig1/AS:881344057995265@1587140206649/A-Progression-free-survival-PFS-and-B-overall-survival-OS-after-multidisciplinary.png)
A, Progression-free survival (PFS) and B, overall survival (OS) after... | Download Scientific Diagram
![Progression-free survival as surrogate end point for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancer† - Annals of Oncology Progression-free survival as surrogate end point for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancer† - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/ab1be0d9-92dd-4944-9de7-f8421b3c1bd4/gr1_lrg.jpg)
Progression-free survival as surrogate end point for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancer† - Annals of Oncology
![Relationship between Progression-free Survival and Overall Survival in Randomized Clinical Trials of Targeted and Biologic Agents in Oncology Relationship between Progression-free Survival and Overall Survival in Randomized Clinical Trials of Targeted and Biologic Agents in Oncology](https://www.jcancer.org/v10/p3717/jcav10p3717g002.jpg)
Relationship between Progression-free Survival and Overall Survival in Randomized Clinical Trials of Targeted and Biologic Agents in Oncology
![Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials - European Journal of Cancer Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials - European Journal of Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/51b81acd-1e61-4f40-bba0-217ef403b59d/gr1.jpg)
Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials - European Journal of Cancer
![Statistical considerations and endpoints for clinical lung cancer studies: Can progression free survival (PFS) substitute overall survival (OS) as a valid endpoint in clinical trials for advanced non-small-cell lung cancer? | Semantic Statistical considerations and endpoints for clinical lung cancer studies: Can progression free survival (PFS) substitute overall survival (OS) as a valid endpoint in clinical trials for advanced non-small-cell lung cancer? | Semantic](https://d3i71xaburhd42.cloudfront.net/2aa8254fae649d2ab35d92abb79d94fa9d17f39e/4-Figure2-1.png)
Statistical considerations and endpoints for clinical lung cancer studies: Can progression free survival (PFS) substitute overall survival (OS) as a valid endpoint in clinical trials for advanced non-small-cell lung cancer? | Semantic
![Background - Progression-Free Survival: What Does It Mean for Psychological Well-Being or Quality of Life? - NCBI Bookshelf Background - Progression-Free Survival: What Does It Mean for Psychological Well-Being or Quality of Life? - NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-methrespfs-lrg.png)
Background - Progression-Free Survival: What Does It Mean for Psychological Well-Being or Quality of Life? - NCBI Bookshelf
![Progression-free survival (PFS) curve and overall survival (OS) curve... | Download Scientific Diagram Progression-free survival (PFS) curve and overall survival (OS) curve... | Download Scientific Diagram](https://www.researchgate.net/profile/Shunsuke-Kondo/publication/259989658/figure/fig4/AS:376440932585476@1466761920292/Progression-free-survival-PFS-curve-and-overall-survival-OS-curve-calculated-using.png)
Progression-free survival (PFS) curve and overall survival (OS) curve... | Download Scientific Diagram
![Cancers | Free Full-Text | Progression-Free Survival Early Assessment Is a Robust Surrogate Endpoint of Overall Survival in Immunotherapy Trials of Hepatocellular Carcinoma | HTML Cancers | Free Full-Text | Progression-Free Survival Early Assessment Is a Robust Surrogate Endpoint of Overall Survival in Immunotherapy Trials of Hepatocellular Carcinoma | HTML](https://www.mdpi.com/cancers/cancers-13-00090/article_deploy/html/images/cancers-13-00090-g001.png)
Cancers | Free Full-Text | Progression-Free Survival Early Assessment Is a Robust Surrogate Endpoint of Overall Survival in Immunotherapy Trials of Hepatocellular Carcinoma | HTML
![PPT - PROGRESSION-FREE SURVIVAL (PFS) AS A SURROGATE FOR OVERALL SURVIVAL ( OS) PowerPoint Presentation - ID:4160976 PPT - PROGRESSION-FREE SURVIVAL (PFS) AS A SURROGATE FOR OVERALL SURVIVAL ( OS) PowerPoint Presentation - ID:4160976](https://image2.slideserve.com/4160976/slide1-n.jpg)
PPT - PROGRESSION-FREE SURVIVAL (PFS) AS A SURROGATE FOR OVERALL SURVIVAL ( OS) PowerPoint Presentation - ID:4160976
![Progression-free survival (PFS) and Overall survival (OS) for all 115 patients with follicular lymphoma according to the prognostic scoring system incorporating the 3 independent risk factors for both PFS and OS. Progression-free survival (PFS) and Overall survival (OS) for all 115 patients with follicular lymphoma according to the prognostic scoring system incorporating the 3 independent risk factors for both PFS and OS.](https://s3-eu-west-1.amazonaws.com/ppreviews-plos-725668748/525896/preview.jpg)
Progression-free survival (PFS) and Overall survival (OS) for all 115 patients with follicular lymphoma according to the prognostic scoring system incorporating the 3 independent risk factors for both PFS and OS.
![Progression-free survival (PFS) (a, c, e) and overall survival (OS) (b,... | Download Scientific Diagram Progression-free survival (PFS) (a, c, e) and overall survival (OS) (b,... | Download Scientific Diagram](https://www.researchgate.net/publication/345656859/figure/fig3/AS:962783071973377@1606556780571/Progression-free-survival-PFS-a-c-e-and-overall-survival-OS-b-d-f-in-melanoma.png)
Progression-free survival (PFS) (a, c, e) and overall survival (OS) (b,... | Download Scientific Diagram
![Progression-free survival (PFS) (A) and overall survival (OS) (B) based... | Download Scientific Diagram Progression-free survival (PFS) (A) and overall survival (OS) (B) based... | Download Scientific Diagram](https://www.researchgate.net/publication/306551418/figure/fig3/AS:567236567855104@1512251144196/Progression-free-survival-PFS-A-and-overall-survival-OS-B-based-on-disease-free.png)
Progression-free survival (PFS) (A) and overall survival (OS) (B) based... | Download Scientific Diagram
![Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma — an IMWG Research Project | Blood Cancer Journal Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma — an IMWG Research Project | Blood Cancer Journal](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41408-018-0155-7/MediaObjects/41408_2018_155_Fig1_HTML.png)
Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma — an IMWG Research Project | Blood Cancer Journal
![Overall survival (OS) and progression-free survival (PFS) curves of... | Download Scientific Diagram Overall survival (OS) and progression-free survival (PFS) curves of... | Download Scientific Diagram](https://www.researchgate.net/profile/Mingju-Cao/publication/267757170/figure/fig1/AS:601663949783061@1520459272821/Overall-survival-OS-and-progression-free-survival-PFS-curves-of-all-stage-patients.png)